PLoS ONE (Jan 2019)

Genotypic antimicrobial resistance assays for use on E. coli isolates and stool specimens.

  • Suporn Pholwat,
  • Jie Liu,
  • Mami Taniuchi,
  • Rattapha Chinli,
  • Tawat Pongpan,
  • Iyarit Thaipisutikul,
  • Parntep Ratanakorn,
  • James A Platts-Mills,
  • Molly Fleece,
  • Suzanne Stroup,
  • Jean Gratz,
  • Esto Mduma,
  • Buliga Mujaga,
  • Thomas Walongo,
  • Rosemary Nshama,
  • Caroline Kimathi,
  • Suporn Foongladda,
  • Eric R Houpt

DOI
https://doi.org/10.1371/journal.pone.0216747
Journal volume & issue
Vol. 14, no. 5
p. e0216747

Abstract

Read online

Antimicrobial resistance (AMR) is an emerging public health problem and methods for surveillance are needed. We designed 85 sequence-specific PCR reactions to detect 79 genes or mutations associated with resistance across 10 major antimicrobial classes, with a focus on E. coli. The 85 qPCR assays demonstrated >99.9% concordance with sequencing. We evaluated the correlation between genotypic resistance markers and phenotypic susceptibility results on 239 E. coli isolates. Both sensitivity and specificity exceeded 90% for ampicillin, ceftriaxone, cefepime, imipenem, ciprofloxacin, azithromycin, gentamicin, amikacin, trimethoprim/sulfamethoxazole, tetracycline, and chloramphenicol phenotypic susceptibility results. We then evaluated the assays on direct stool specimens and observed a sensitivity of 97% ± 5 but, as expected, a lower specificity of 75% ± 31 versus the genotype of the E. coli cultured from stool. Finally, the assays were incorporated into a convenient TaqMan Array Card (TAC) format. These assays may be useful for tracking AMR in E. coli isolates or directly in stool for targeted testing of the fecal antibiotic resistome.